These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 29260741)

  • 1. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
    Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
    Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the cytokine profile and peripheral blood lymphocyte subpopulations in patients with chronic viral hepatitis B and C in comparison to severity of morphological changes of the liver].
    Lazareva AS; Volchkova EV; Umbetova KT; Chulanov VP; Parkhomenko IuG; Kiselevskiĭ MV; Pak SG
    Ter Arkh; 2009; 81(4):55-60. PubMed ID: 19514423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-lymphocyte subsets in peripheral blood and liver tissue of patients with chronic hepatitis B and C.
    Dimitropoulou D; Karakantza M; Tsamandas AC; Mouzaki A; Theodorou G; Gogos CA
    In Vivo; 2011; 25(5):833-40. PubMed ID: 21753143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C.
    Akcam FZ; Tigli A; Kaya O; Ciris M; Vural H
    J Interferon Cytokine Res; 2012 Dec; 32(12):570-4. PubMed ID: 23067363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.
    Wang L; Qiu J; Yu L; Hu X; Zhao P; Jiang Y
    J Transl Med; 2014 Sep; 12():251. PubMed ID: 25199644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C.
    Verveer C; Zondervan PE; ten Kate FJ; Hansen BE; Janssen HL; de Knegt RJ
    Liver Int; 2012 Apr; 32(4):622-8. PubMed ID: 22098684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
    Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.
    Öksüz Z; Üçbilek E; Serin MS; Yaraş S; Temel GO; Sezgin O
    Braz J Microbiol; 2020 Dec; 51(4):1757-1763. PubMed ID: 32959205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus.
    Sobhy A; Fakhry M M; A Azeem H; Ashmawy AM; Omar Khalifa H
    J Investig Med; 2019 Mar; 67(3):681-685. PubMed ID: 30385593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.
    Manolakopoulos S; Bethanis S; Liapi C; Stripeli F; Sklavos P; Margeli A; Christidou A; Katsanika A; Vogiatzakis E; Tzourmakliotis D; Theocharis S
    BMC Gastroenterol; 2007 May; 7():17. PubMed ID: 17540037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.
    Nielsen MJ; Karsdal MA; Kazankov K; Grønbaek H; Krag A; Leeming DJ; Schuppan D; George J
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1242-1252. PubMed ID: 27696451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood T, B, and NK cells in relation to histological hepatitis activity and fibrosis stage in chronic hepatitis C.
    Panasiuk A; Prokopowicz D; Zak J; Wysocka J
    Hepatogastroenterology; 2003; 50(49):178-82. PubMed ID: 12630018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.
    Sturm N; Marlu A; Arvers P; Zarski JP; Leroy V
    Liver Int; 2013 Mar; 33(3):428-38. PubMed ID: 23402612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
    Liu X; He L; Han J; Wang L; Li M; Jiang Y; Wang X; Yang Z
    PLoS One; 2017; 12(2):e0170605. PubMed ID: 28231294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis.
    Zografos TA; Rigopoulou EI; Liaskos C; Togousidis E; Zachou K; Gatselis N; Germenis A; Dalekos GN
    J Hepatol; 2006 May; 44(5):848-55. PubMed ID: 16530290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation in patients with chronic hepatitis C.
    Fusegawa H; Shiraishi K; Ogasawara F; Shimizu M; Haruki Y; Miyachi H; Matsuzaki S; Ando Y
    Tokai J Exp Clin Med; 2002 Dec; 27(4):101-6. PubMed ID: 12713014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.